Not saying no market. I think the potential private pie is diminishing.

Like this how?
------------------

Earlier, Khairy said the Covid-19 Vaccine Supply Access Guarantee Committee would also discuss the decision to provide free Covid-19 vaccination to foreign workers, expatriates and permanent residents in the country.

Khairy said a meeting will be held jointly with ministries from Human Resources, Home and Foreign at the end of the month.

He said this was to allow the government to cover as many foreign workers as possible.

"The principle is simple, we need to vaccinate them (foreign workers) to ensure that we are all safe.

"The more we vaccinate, the safer we wil become. If we ask them or their employers to pay, it could become an obstacle for them.


https://www.msn.com/en-my/news/national/details-of-vaccine-purchasing-contracts-revealed-to-pac/ar-BB1cu99p?ocid=msedgntp

Like this how?
------------------

Earlier, Khairy said the Covid-19 Vaccine Supply Access Guarantee Committee would also discuss the decision to provide free Covid-19 vaccination to foreign workers, expatriates and permanent residents in the country.

Khairy said a meeting will be held jointly with ministries from Human Resources, Home and Foreign at the end of the month.

He said this was to allow the government to cover as many foreign workers as possible.

"The principle is simple, we need to vaccinate them (foreign workers) to ensure that we are all safe.

"The more we vaccinate, the safer we wil become. If we ask them or their employers to pay, it could become an obstacle for them.

https://www.msn.com/en-my/news/national/details-of-vaccine-purchasing-contracts-revealed-to-pac/ar-BB1cu99p?ocid=msedgntp

Political instability. Trade with caution.

Seemed like KStar Healthcare got some news. Why Kanger so quiet?

The Board of Directors of K-Star wishes to announce that K Star Healthcare Sdn. Bhd. (“K Star Healthcare”), the wholly-owned subsidiary of the Company, has on 4 January 2021 entered into a Provisional Offtake Agreement (“POA”) with AT Glove Engineering Sdn. Bhd. (“ATGE”), a wholly-owned subsidiary of AT Systematization Berhad (“AT Systematization”) for promoting, marketing, selling of medical glove product to the People’s Republic of China (“China”) and Taiwan.

Please refer to the attachment for details of the announcement and press release.

This announcement is dated 4 January 2021.

The Board of Directors of K-Star wishes to announce that K Star Healthcare Sdn. Bhd. (“K Star Healthcare”), the wholly-owned subsidiary of the Company, has on 4 January 2021 entered into a Provisional Offtake Agreement (“POA”) with AT Glove Engineering Sdn. Bhd. (“ATGE”), a wholly-owned subsidiary of AT Systematization Berhad (“AT Systematization”) for promoting, marketing, selling of medical glove product to the People’s Republic of China (“China”) and Taiwan.

Please refer to the attachment for details of the announcement and press release.

This announcement is dated 4 January 2021.

How many times have to U turn? Every time got hope, sure got politics come and disturb..sien.

These countries are not easy to penetrate and the demographics of the population is another factor to consider.

Stock prices reset..system reboot...back to factory settings

New year, New Day, New Hope..

Wait long long...tan ku ku

PETALING JAYA: Pulai Umno became the first division in the country to pass a resolution asking party leaders to quit the Perikatan Nasional (PN) government immediately to force a general election.

Its head Nur Jazlan Mohamed, who confirmed this to FMT, said the delegates at the annual general meeting on Friday had unanimously decided that it would be in the best interest of Umno and its reputation to leave the ruling coalition before the party is also blamed for the failure of PN to govern properly.

In a strongly-worded resolution which was sighted by FMT, the division described the coalition’s top leaders as untrustworthy and who have no qualms about ditching their allies for power.

This is what I see....assuming everything is good.

Formalise distributorship agreement – January 2021
Submit for MOH approval – Febuary
Obtain approval – April
Places orders - April
Lead time – 4 months (Superfast priority)
Earliest Vaccine arrive – August
Actual impact on revenue performance – Sept / Dec 2021
QR reporting – March 2022

Now let's look back at the share value....
and do some analysis on competitors and private market share whatever there's left after Government orders.

@Steady..before we go off road, I am never an anti Sinopharm. I will support this vaccine regardless Government procured or private supplied. Me posting articles on Sinopharm is for general knowledge.

My interest here is on Kanger performance and consequences on the share price movements. That's the main objective. Therefore the focus is on the company. Let's not get distracted.
I hope Kanger management would monitor this forum and get the message.

Pls take queue number:

Coronavirus: a flurry of international orders for Chinese vaccines
At least 10 countries have signed up for the shots from Sinopharm and other providers

https://www.scmp.com/news/china/science/article/3116135/coronavirus-flurry-international-orders-chinese-vaccines

Demand is very high = long delivery time = delayed supplies = delayed sales = ?QR
Kanger better get off starting block quick quick.

Willingness to get COVID inoculations strong

By WANG XIAOYU in Beijing and CHAI HUA in Shenzhen, Guangdong | China Daily | Updated: 2020-12-31 06:56

A resident is given a COVID-19 inoculation at a community health center on Wednesday in Shenzhen, Guangdong province. CHAI HUA/CHINA DAILY
People qualified to get an emergency inoculation against COVID-19 in China have shown a strong willingness to take the shot, as evidence of homegrown vaccines' safety and efficacy continues to build, boosting the public's confidence.

Leading vaccine developer Sinopharm said on Wednesday that an inactivated vaccine candidate created by a company unit in Beijing is 79.34 percent effective in protecting people against the virus and is generally safe, citing interim results from stage 3 clinical trials.

The newly released efficacy rate has met requirements set by the World Health Organization and the National Medical Products Administration, the company said in a statement released on its website.

The product can also induce a high level of neutralizing antibodies in 99.52 percent of recipients. This indicates that nearly all of them have generated immune responses against the virus, but not all responses are necessarily strong enough to fend it off.

With these new developments, the company said it has already submitted an application for market approval to the top drug regulator, making it the first domestic vaccine developer to announce the crucial move.

The experimental dose, developed by Sinopharm's Beijing Biological Products Institute, is one of three vaccines being rolled out for an emergency inoculation program targeting high-risk groups nationwide since July.

The high-risk population includes those traveling to medium-or high-risk areas for work or study, as well as workers in customs, healthcare, the cold-chain industry and other public service sectors, according to the National Health Commission.

Nearly 1 million people had received emergency doses as of late December, the commission said.

As evidence on domestically developed vaccines accumulates and official market approval draws closer, the emergency campaign is proceeding smoothly across the country and has been met with high acceptance from the public, officials said.

In Shenzhen, Guangdong province, five community clinics began vaccinating people against the virus this week. The two-dose vaccination is free of charge, but appointment slots are limited, according to the local government.

On Tuesday, people waiting to get the shot were lined up at one of the centers in Nanshan district while more than a dozen medical workers were busy checking their information, setting up personal health files, administering the dose and confirming the date for the second shot.

Among the recipients was Yan Weifan, a new graduate from a university in Hong Kong. He planned to travel to Hong Kong soon to get his diploma, which made him eligible for the emergency program.

Yan said he waited for about an hour at the health center to get the shot and was instructed to remain there for 30 minutes for medical observation before leaving.

"It felt like having a normal injection, with a little sore and swollen feeling," he said.

Song Shuyi, director of the health center, said about 400 people were vaccinated on Monday, most of them students who plan to study abroad.

High demand

In Jinan, Shandong province, two hospitals were designated to administer emergency doses starting over the weekend, according to the city's health commission.

Hospital workers stayed busy all day on Tuesday fielding calls about the vaccinations and booking slots, according to a medical worker at one Jinan hospital who declined to give his name.

A similar eagerness to get vaccinated was reported in Wuhan, Hubei province, which began emergency inoculations on Dec 24 at 48 health clinics across the city.

"I hope to get vaccinated as soon as possible so that I do not need to present nucleic acid test results each time I get a new job," said a 43-year-old housekeeper in Wuhan whose surname is Wang.

In response to the high demand, local governments are stocking up on emergency doses and accelerating vaccinations for high-risk groups while abiding by regulations.

Jing Jing, a senior official at Sichuan province's health commission, said during a conference on Dec 17 that the commission planned to complete administering the first doses to all key groups by Jan 15 and to finish the second injections by Feb 5.

Health authorities said during a previous conference that annual manufacturing capacity for the vaccines in China will exceed 1 billion by the end of 2021.

Liu Kun in Wuhan, Zhao Ruixue in Jinan and Zhang Zhihao in Beijing contributed to this story.

Probably G to G discounts. Don’t think cheap prices apply for private deals. Nevertheless let’s hope for the best.

Hepatitis B Vaccine cost almost the same about RM 60 - 80 per dose and you need 3 doses.

Sinopharm is definitely good. I am willing take this vaccine over Pfizer too.
And I think Government will procure Sinopharm as well as it is the only one approved so far. Cansino and Sinovac is still in trials.

I am just concerned with Kanger , the company only before I dive in further.

Looks like Kanger Chairman Datuk Nur Jazlan is not happy with our Government. Will it affect business relationship?

------------------------------------------------------------------------------------

(The Star) – The Pulai Umno division will push for a motion to call for the party to withdraw its support for the Perikatan Nasional-led government, says its chief Datuk Nur Jazlan Mohamed.

He said that there were cracks appearing within the Perikatan government and it would be wise for Umno to “pack its bags and leave”.

“There is no trust between Umno and Parti Pribumi Bersatu Malaysia, where a small party dictates a bigger party.

“We can see that the present government has minority support in Parliament with majority of their support coming from the more than 30 Umno MPs,” he added.

He said this after launching the division’s Wanita wing meeting here on Friday (Jan 1).

Nur Jazlan, who is also Johor Umno deputy chief, added that the Umno supreme council was expected to make a decision by March if the party would continue supporting Perikatan.

He believed other Umno divisions throughout the country would also come up with similar motions.

“When the present government does any good, Umno will not gain anything – but if their actions backfire, Umno gets the brunt of it,” he said.

The former Pulai MP said if Umno withdrew its support for the Perikatan government, then a snap general election would be held and urged the division members to carry out necessary preparations.

He added that the division would not let go any of its traditional seats such as the Pulai parliamentary and Kempas state seats to Bersatu.

18K, just ignore this fella....

Rocket Boom Monday!! All the best.

Shoot, Not fair for me to post my guess, I can only post what is info is available. If I can guess correctly, I would be a very rich man. Hahahaha...

One of Mah Sing project in Medini, Nusajaya. HSR cancellation bad for this project.

Nur Jazlan is just a Chairman. He is not hands on operationally.

There’s nothing wrong with Sinopharm vaccine but something is wrong with Kanger BOD.

Since August 2020 till December 2020, 8 Directors of Kanger had resigned. Most of them are related to substantial shareholders. Apparently there’s a change in BOD and course of business direction. It would be very useful if BOD come out with future business plan.

1. Chong Amita Non Independent Director Resigned 24/8/20 (Son of substantial shareholder Lim Lai Chong)
2. Kuan Ah Hock Deputy Chairman Resigned 28/8/20 (Partner in substantial shareholder Setiakon)
3. Syed Hazrain Jamalullail Executive Director Resigned 28/8/20 (Perlis Royalty and son of Dato Paduka Sharipah)
4. Kenneth Hooi Executive Director Resigned 28/8/20
5. Lim Yong Lee Director Resigned 2/9/20
6. Dato’ Haji Markiman Director Resigned 2/9/20 (Ex Umno MP for Hulu Langat 2004)
7. Dato’ Paduka Sharipah Chairman resigned 28/9/20 (Member of Perlis Royalty)
8. Datuk Seri Dr Zabid Director Resigned 31/12/20 (Director since Kanger was listed in 2014)

Kanger need to firm up the formal distributorship agreement with Sinopharm. The MOU they signed is not binding yet. And the general agreement is they are will be given priority, not sole & exclusive. Only after they done so, then only they have access to test data to submit to MOH for approval. And queue for the vaccine to be allocated to them.

So until these are announced, I will still take things with a pinch of salt. Kanger is too quiet for now.

Private sector got too many players for too few business. Roti Canai open up too many possibilities. One day say this next day say that. If kanger not strong, then will have problems.

For now, this vaccine business is still full of speculations, assumptions and predictions. It is there yet not really there type of scenario.

I don't think Halal is an issue but potential side effects. I talk to some of my Muslim friends and they are of opinion that if they are unable to make personal judgement, all needed is the authorities say it is ok to take, they will accept.

@Steady..we think need a heads up on this submission. hehehe

It appears Sinopharm approval is not complete but conditional. Will our Government MOH accept this conditional approval?

"A Sinopharm company executive said Thursday the vaccine's Phase 3 trials covered more than 60,000 people, while detailed data will be released later and published in scientific journals at home and abroad.

An official with China's drug regulator said the vaccine's clinical trials are still ongoing, and its manufacturer will be required to submit follow-up data to authorities."

Good luck to all. Happy New Year 2021. Harap tahun baru ni terbaik dalam kehidupan dan keluarga semua.

Dato Seri Dr. Md Zabid bin Haji Abd Rashid resigned as Independent and Non Executive Director.

You guys may wish to know "distribution of vaccine" is included in the nature of business of GI Healthcare.

Approval of Sinopharm is one thing, Kanger as the distributor is another.

Any other company would seize the moment to holding a press conference informing what their plans are now that vaccine has been approved. But Kanger is suspiciously quiet on this. Maybe they will announce later as their MOU require them to sign a formal distributorship agreement.

Kstar on the run

Unless it is earth shattering announcement, market seemed to be very cool to Kanger prices. Otherwise it would be like other vaccine counters.

It is a viable business if Solutions is a total healthcare pharmaceutical business but if it is just a vaccine business, it's a bit risky. Just one dish won't get you very far.

Right now, no one dare say whose quality is better as they are no studies as data over time not available yet. Also many claimed theirs is better, but claims remained as claims. No peer reviews no transparencies, no release of data make these more difficult.

https://www.youtube.com/watch?v=yZxfj9KSPBw&feature=youtu.be

Don't be mistaken. I also will go to my regular private hospitals. I am just saying overall situation. The fear of side effects, the religious beliefs, why the urgency, etc. Maybe small portion of public will take.
Lately, people do not care about going out in public areas. They are worried but they no fear of Covid19. They all go to Melaka, Langkawi for holidays. Which means they will not purposely go for jabs unless they need to.

Private hospitals only for elites...what's the volume of business?

More so if jab in Government hospital, any side effects, Government will treat.
Jab at private hospitals, who pay for treatments if there's complications?

Average price is USD 20 per dose x 2 = USD 40 per person.
Who wants to pay when Government is giving FOC?

It is a fishing trip la...yesterday price hiked up in short time with little volume..today hope investors chase high so they can sell...but failed to materialise.

Maybe roti canai and tosai quietly goreng kaw kaw. It is all a game of perception and shadow play. Keep money in bank, standby and just wait until picture is clearer. Stock market won't run away, don't worry if miss the bus. There's always another one coming.

Finito..